A Single-Dose, Three-Way, Three-Sequence, Crossover BA Study of Azithromycin Oleogel

NCT05796362 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Infectious Disease
Drug Effect
Clinical Infection

Interventions

DRUG: Azithromycin Oleogel (Oral and Rectal)

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]